Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

PANDA Therapeutics secures €160K from Venture Kick to advance its multi-target Alzheimer’s therapy towards clinical development.

PRIVATEAug 31, 2026•3 days ago

Amount Raised

€160,000

Round Type

Pre-Seed

BiotechnologyHealth CareTherapeutics

Investors

Venture Kick

Description

PANDA Therapeutics has obtained €160,000 from Venture Kick to advance a new treatment for Alzheimer’s disease. The funding will primarily support company formation and business development. Its innovative treatment targets multiple protein deposits simultaneously. This approach aims to provide a broader and longer-lasting solution for Alzheimer’s progression.

Company Information

Company

PANDA Therapeutics

About

PANDA Therapeutics is a biotech startup focused on developing a first-in-class antibody-based therapy for Alzheimer’s disease. The company aims to target multiple harmful protein deposits in the brain simultaneously, improving treatment effectiveness and slowing disease progression. Founded by CEO Hui Zhang, who has extensive experience in drug discovery in Neuroscience, PANDA seeks to engage global pharmaceutical and biotechnology companies as strategic partners.

Don't miss PANDA Therapeutics's next move

Get an email the moment PANDA Therapeutics raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for PANDA Therapeutics's next move

See what Strategic adds

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

PANDA Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.